
TREATMENTS
Exploring new frontiers for the treatment of Autoimmune Disorders
TREATMENTS
Exploring new frontiers for the treatment of Autoimmune Disorders
17+ Years of using patented and proven stem cell treatment for Auto Immune Disorders
Your body's immune system protects you from disease and infection. Autoimmune disorders occur when the body's immune system attacks and destroys healthy body tissues instead of viruses and bacteria. Autoimmune diseases can affect many parts of the body by damaging or destroying tissues, altering organ growth and functions.
As such, there is no cure conventionally for Autoimmune Disorders. Medications may help relieve the pain temporarily. Anti-inflammatory drugs or steroidal medicines are commonly prescribed. Treatment depends on the type and severity of the condition. While treatment usually improves symptoms, they do not typically cure the disease. With Stem Cell Treatment, new cells are administered in the body that are capable of differentiating into other cells as required and can be used to treat damaged tissue or organs to regenerate lost or impaired functions.
Stem cells can differentiate into lost or damaged tissue or organs to regenerate lost or improve on the impaired functions. After the successful therapy, patients have shown remarkable improvements across a variety of screening criterions.
At Nutech MediWorld, the patients’ clinical condition is assessed for safety and efficacy of the treatment using conventional systems to check their eligibility for stem cell treatment for Autoimmune Disorders.
We also conduct an additional round of thorough assessment using our patented NFS (Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem®.
The patient’s progress is monitored on a weekly basis to further optimise treatment protocols depending on the patient’s response.
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Autoimmune Disorder patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Autism Patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient
At Nutech MediWorld, the patients’ clinical condition is assessed for safety and efficacy of the treatment using conventional systems to check their eligibility for stem cell treatment for Autoimmune disorders.
We also conduct an additional round of thorough assessment using our patented NFS (Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem ®.
The patient’s progress is monitored on a weekly basis to further optimise treatment protocols depending on the patient’s response.
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended.
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®. ReoStem® is a unique, replicable, clinical-stage technology platform for the generation of allogenic stem cells.
Nutech MediWorld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
There is absolutely no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Unique cell culture methodology allows scalability of cell expansion and production.